174 related articles for article (PubMed ID: 36863922)
21. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1277-87. PubMed ID: 18506484
[TBL] [Abstract][Full Text] [Related]
22. Recurrent vaginal epithelioid leiomyosarcoma; a case report from Botswana and review of the literature.
Benti TM; Mercy N; Eshetu AB; Iwuh IE; Kassa MW
Afr J Reprod Health; 2021 Feb; 25(1):161-168. PubMed ID: 34077121
[TBL] [Abstract][Full Text] [Related]
23. Impact of guideline adherence and expert center referral on the early management and outcomes of uterine sarcoma patients: A retrospective analysis from the French NETSARC network.
Richaud C; Jochum F; Journo G; Toussaint A; Laurent M; Fontier Z; Langer A; Malhaire C; Laas E; Féron JG; Lecuru F; Pouget N; Guinebretière JM; El Zein S; Brain E; Watson S; Piperno-Neumann S; Blay JY; Bonvalot S; Bozec L; Hamy AS
Eur J Surg Oncol; 2024 Feb; 50(2):107319. PubMed ID: 38159391
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
[TBL] [Abstract][Full Text] [Related]
25. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
[TBL] [Abstract][Full Text] [Related]
26. Management of advanced stage uterine sarcomas: a bone of contention.
Zagouri F; Linardou H; Dimopoulos AM; Papadimitriou CA
Eur J Gynaecol Oncol; 2009; 30(5):483-92. PubMed ID: 19899397
[TBL] [Abstract][Full Text] [Related]
27. A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China.
Li D; Yin N; Du G; Wang S; Xiao Z; Chen J; Chen W
Int J Biol Sci; 2020; 16(3):388-395. PubMed ID: 32015676
[TBL] [Abstract][Full Text] [Related]
28. Uterine sarcomas--recent progress and future challenges.
Seddon BM; Davda R
Eur J Radiol; 2011 Apr; 78(1):30-40. PubMed ID: 21247711
[TBL] [Abstract][Full Text] [Related]
29. Uterine sarcoma 2008.
Lin JF; Slomovitz BM
Curr Oncol Rep; 2008 Nov; 10(6):512-8. PubMed ID: 18928666
[TBL] [Abstract][Full Text] [Related]
30. Uterine sarcoma. Clinico-pathological characteristics and outcome.
Sait HK; Anfinan NM; El Sayed ME; Alkhayyat SS; Ghanem AT; Abayazid RM; Sait KH
Saudi Med J; 2014 Oct; 35(10):1215-22. PubMed ID: 25316466
[TBL] [Abstract][Full Text] [Related]
31. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
[TBL] [Abstract][Full Text] [Related]
32. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
[TBL] [Abstract][Full Text] [Related]
33. The role of adjuvant therapy in uterine leiomyosarcoma.
Ducie JA; Leitao MM
Expert Rev Anticancer Ther; 2016; 16(1):45-55. PubMed ID: 26558647
[TBL] [Abstract][Full Text] [Related]
34. Uterine sarcomas.
Ganjoo KN
Curr Probl Cancer; 2019 Aug; 43(4):283-288. PubMed ID: 31235185
[TBL] [Abstract][Full Text] [Related]
35. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
[TBL] [Abstract][Full Text] [Related]
36. [Postoperative radiotherapy of uterine sarcoma: a multicentric retrospective study].
Champetier C; Hannoun-Levi JM; Resbeut M; Azria D; Salem N; Tessier E; Ellis S; Cowen D;
Cancer Radiother; 2011 Apr; 15(2):89-96. PubMed ID: 20674447
[TBL] [Abstract][Full Text] [Related]
37. Uterine Sarcomas: The Latest Approaches for These Rare but Potentially Deadly Tumors.
Chern JY; Boyd LR; Blank SV
Oncology (Williston Park); 2017 Mar; 31(3):229-36. PubMed ID: 28299760
[TBL] [Abstract][Full Text] [Related]
38. Optimal management of uterine leiomyosarcoma.
O'Cearbhaill R; Hensley ML
Expert Rev Anticancer Ther; 2010 Feb; 10(2):153-69. PubMed ID: 20131992
[TBL] [Abstract][Full Text] [Related]
39. Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.
Multinu F; Casarin J; Tortorella L; Huang Y; Weaver A; Angioni S; Melis GB; Mariani A; Stewart EA; Laughlin-Tommaso SK
Am J Obstet Gynecol; 2019 Feb; 220(2):179.e1-179.e10. PubMed ID: 30447212
[TBL] [Abstract][Full Text] [Related]
40. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]